user
menu
letter
Sign InRegister
langEnglisharrow

Cat. No. / Size
Price
Availability
Qty
HLE-H52H9-25ug
$290.00
Inquire about delivery time
HLE-H52H9-200ug
$1,650.00
Inquire about delivery time
HLE-H52H9
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
Request Quote
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources

  • Synonyms

    HLA-A*0201 & B2M & PRAME (SLLQHLIGL)

  • Source

    Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Tetramer Protein (HLE-H52H9) is expressed from human 293 cells (HEK293). It contains AA Ile 21 - Met 119 (B2M) & Gly 25 - Ile 308 (HLA-A*02:01) & SLLQHLIGL peptide (Accession # P61769 (B2M) & AAA59606.1 (HLA-A*02:01) & SLLQHLIGL).

  • Molecular Characterization

    Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Tetramer Protein is assembled by biotinylated monomer (HLE-H82E8) and streptavidin.

    Biotinylated Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Complex Protein is produced by co-expression of HLA and B2M loaded with PRAME peptide. Biotinylated Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Complex Protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 51.3 kDa and 13.8 kDa. The protein migrates as 55-60 kDa and 12 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Background

This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants. The PRAME (SLLQHLIGL) was shown to be recognized by HLA-A*0201 tumor-infiltrating lymphocytes from melanoma patients, and therefore it is widely been studied in TCR-T studies. The Human HLA-A*0201 PRAME (SLLQHLIGL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and PRAME (SLLQHLIGL) peptide.